Your Health, We Care
Release date: 2025-04-17 10:26:02 Recommended: 33
Knowing the dosage of a drug is an important basis for rational drug use.
For adult patients, the usual starting dose of finerenone is 10 mg daily.
The dose can be adjusted to 20 mg per day based on clinical response and tolerability assessment. Study data showed that more than 87% of subjects achieved the desired treatment effect in the range of 10-20 mg.
Patients with a glomerular filtration rate of less than 30 mL/min/1.73 m² should be used with caution. It is recommended to halve the initial dose for patients with moderately impaired liver function, and it is not recommended for patients with severe liver impairment. Older people do not need to specifically adjust the dose, but increased monitoring is required.
Serum potassium levels should be measured every 4 weeks at the beginning of treatment, and if it is consistently higher than 5.0 mmol/L, a 50% dose reduction should be considered. If systolic blood pressure is less than 90 mmHg, it is recommended to discontinue the drug until blood pressure stabilizes. When used in combination with strong CYP3A4 inhibitors, the daily dose should not exceed 10 mg.
Standardized medication needs to be combined with an individualized treatment plan.
It is recommended to take it at a fixed time daily with food, which can increase bioavailability by 23%. The dose can be retaken within 4 hours after the missed dose, and the dose should be skipped after this limit. Clinical trials have confirmed that significant results can be seen after 12 weeks of continuous use.
The market price for a 30-piece pack is around $120-$150, and there are price differences between different brands. Some insurance plans can cover 60%-80% of the cost, and Medicaid patients can apply for special subsidies. The price of generic drugs may drop by about 40% after they are launched.
Urine albumin/creatinine ratio should be measured regularly during treatment, and the ideal reduction should be more than 30%. The glomerular filtration rate should be monitored quarterly, and the annual decline rate should be controlled within 2ml/min. ECG monitoring can prevent potential heart conduction abnormalities.
Rational use of finerenone requires the involvement of both the doctor and the patient, and timely adjustment of the regimen through regular assessment. Strict adherence to dosage specifications and monitoring requirements is required to achieve the best treatment results. The medical team should dynamically optimize the treatment strategy based on real-time data to provide accurate medical services to patients.
